These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8965505)

  • 1. [Quality assurance of the basic list of drugs].
    Wallén L; von Bahr C
    Lakartidningen; 1996 Oct; 93(41):3550, 3552. PubMed ID: 8965505
    [No Abstract]   [Full Text] [Related]  

  • 2. [Feedback on prescribing profiles at a primary health center. Important element in quality assurance of drug prescription].
    Nyman K; Bergens A; Björin AS; Guterstam P; Nyrén O; Jansson U; Wettermark B; Bergman U
    Lakartidningen; 2001 Jan; 98(3):160-4. PubMed ID: 11271576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Safer drug handling in hospitals. A new task for the drug committee].
    Osterman PO; Gyllenspetz L; Hartvig P; Levol R; Rane A; Söderström A
    Lakartidningen; 1996 Oct; 93(44):3917-20. PubMed ID: 8965581
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of essential drugs.
    WHO Expert Committee
    World Health Organ Tech Rep Ser; 2000; 895():1-61. PubMed ID: 11286007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caution advised with quality assurance consultants.
    Cramer RL
    Am J Hosp Pharm; 1991 Sep; 48(9):1891-2. PubMed ID: 1928124
    [No Abstract]   [Full Text] [Related]  

  • 6. The focus on true value in the health care system.
    Giaquinta D
    Manag Care Interface; 2007 Apr; 20(4):40-1. PubMed ID: 17474329
    [No Abstract]   [Full Text] [Related]  

  • 7. Letter: Discrepancy in article on pharmaceutical quality.
    Hoar ME
    Am J Hosp Pharm; 1976 Jun; 33(6):533. PubMed ID: 1274969
    [No Abstract]   [Full Text] [Related]  

  • 8. P & T Committee interview: Promoting rational drug use.
    Hunt TK; Herfindal ET
    Hosp Formul; 1988 Apr; 23(4):359-62, 365-6, 369. PubMed ID: 10286839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automating the pharmacy and therapeutics process: driving a safer and more cost-effective future.
    Inguanti ME
    Manag Care Interface; 2007 Mar; 20(3):13-4. PubMed ID: 17458474
    [No Abstract]   [Full Text] [Related]  

  • 10. The case for a value-based formulary: striving for total lowest net cost.
    Weart W; Bauman GR
    Manag Care Interface; 2007 Apr; 20(4):42-7. PubMed ID: 17474330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug committee: committee is going to bring about a more knowledgeable attitude to the selection of drugs].
    Hagelsten JO
    Sygeplejersken; 1978 Mar; 78(12):4-7, 20. PubMed ID: 247708
    [No Abstract]   [Full Text] [Related]  

  • 12. Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevance.
    Godman B; Wettermark B; Hoffmann M; Andersson K; Haycox A; Gustafsson LL
    Expert Rev Pharmacoecon Outcomes Res; 2009 Feb; 9(1):65-83. PubMed ID: 19371180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Approval of drugs by national and European agencies--from the viewpoint of drug approval committee A].
    Henschler D
    Z Arztl Fortbild Qualitatssich; 1997 Nov; 91(7):600-3. PubMed ID: 9527449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The right drug to the right patient in a right dosage is the goal of clinical pharmacology].
    Lindell B
    Lakartidningen; 1984 May; 81(19):1931-43. PubMed ID: 6727471
    [No Abstract]   [Full Text] [Related]  

  • 15. Praxis less than perfect.
    Asch DA
    Hastings Cent Rep; 1994; 24(6):41. PubMed ID: 7860290
    [No Abstract]   [Full Text] [Related]  

  • 16. Psychopharmacological screening criteria.
    Peterson GN
    J Clin Psychiatry; 1993 Oct; 54(10):397-8. PubMed ID: 7903294
    [No Abstract]   [Full Text] [Related]  

  • 17. The P&T Committee's role in managing drugs for rare diseases.
    Tadlock C
    Manag Care Interface; 2007 Jun; 20(6):10, 13. PubMed ID: 17708076
    [No Abstract]   [Full Text] [Related]  

  • 18. [Drug committees towards the regions. The Danish Society of Clinical Pharmacology].
    Reuther LØ; Brock B;
    Ugeskr Laeger; 2007 Mar; 169(12):1113. PubMed ID: 17394824
    [No Abstract]   [Full Text] [Related]  

  • 19. How a longstanding P & T Committee identifies and meets current therapeutic challenges.
    Stross J; de Leon R; Volger B
    Hosp Formul; 1991 Sep; 26(9):717-22, 724. PubMed ID: 10114003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kenya: updating the Essential Drugs List.
    Essent Drugs Monit; 1993; (16):16-7. PubMed ID: 12319051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.